PD-1 controls differentiation, survival, and TCR affinity evolution of stem-like CD8+ T cells
Hor, J. L.; Schrom, E. C.; Wong-Rolle, A.; Vistain, L.; Shang, W.; Dong, Q.; Zhao, C.; Jin, C.; Germain, R. N.
Show abstract
Stem-like progenitors are a critical subset of cytotoxic T cells that self-renew and give rise to expanded populations of effector cells critical for successful checkpoint blockade immunotherapy. Emerging evidence suggests that the tumor-draining lymph nodes can support the continuous generation of these stem-like cells that replenish the tumor sites and act as a critical source of expanded effector populations, underlining the importance of understanding what factors promote and maintain activated T cells in the stem-like state. Using advanced 3D multiplex immunofluorescence imaging, here we identified antigen-presentation niches in tumor-draining lymph nodes that support the expansion, maintenance, and affinity evolution of a unique population of TCF-1+PD-1+SLAMF6hi stem-like CD8+ T cells. Our results show that contrary to the prevailing view that persistent TCR signaling drives terminal effector differentiation, prolonged antigen engagement well beyond the initial priming phase sustained the proliferation and self-renewal of these stem-like T cells in vivo. The inhibitory PD-1 pathway plays a central role in this process by mediating the fine-tuning of TCR and co-stimulatory signal input that enables selective expansion of high affinity TCR stem-like clones, enabling them to act as a renewable source of high affinity effector cells. PD-1 checkpoint blockade disrupts this fine tuning of input signaling, leading to terminal differentiation to the effector state or death of the most avid anti-tumor stem-like cells. Our results thus reveal an unexpected relationship between TCR ligand affinity recognition, a key negative feedback regulatory loop, and T cell stemness programming. Furthermore, these findings raise questions about whether anti-PD-1 checkpoint blockade during cancer immunotherapy provides a short-term anti-tumor effect that comes at the cost of diminishing efficacy due to progressive loss of these critical high affinity stem-like precursors.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A novel RORγt+ antigen presenting cell type instructs microbiota-dependent regulatory T cell differentiation and tolerance during early life 99%
- Atlas-Guided Discovery of Transcription Factors for T Cell Programming 99%
- Precancer: Mutant clones in normal epithelium outcompete and eliminate esophageal micro-tumors 99%
Similar papers in this journal
- Slowly evolving dopaminergic activity modulates the moment-to-moment probability of movement initiation. 97%
- linc-mipep and linc-wrb encode micropeptides that regulate chromatin accessibility in vertebrate-specific neural cells 97%
- Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation 97%
Similar papers in this journal
- Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers 96%
- Soluble CTLA-4 mainly produced by Treg cells inhibits type 1 inflammation without hindering type 2 immunity to allow for inflammation resolution 95%
- Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.